Cytokinetics | CYTK - Ebit



金融业
股票价格
USD 56.13
资产
USD 1.82B
现金及等价物
USD 203.43M
销售成本
USD 2.22M
流动资产
USD 1.19B
流动负债
USD 353.42M
债务
USD 1.27B
EBIT
USD -167.09M
EBITDA
USD -160.3M
员工
498
EPS每股收益
USD -1.37
股本和储备
USD -321.17M
销售毛利
USD 45.34M
债务利息支出
USD 38.48M
利息收入
USD 13.94M
贷款资金
USD 244.33M
市值
USD 6.63B
净收入
USD -190.07M
营业费用
USD 214.65M
营业利润
USD -167.09M
普通股股本
USD 138.76M
税前利润
USD -198.76M
销售收入
USD 47.6M
销售和管理费用
USD 113.14M
股票
USD 807K
贸易债权人
USD 25.96M
应收帐款人
USD 24.43M


Ebit 更改 日
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Amgen USD 4.68B 65M 2026-09
Arca Biopharma USD -36.43M 2M 2026-03
Bayer EUR 129M 626M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Brainstorm Cell Therapeutics USD -2.05M 1000 2026-03
Bristol-Myers Squibb USD 255M 44M 2026-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cytokinetics USD -167.09M 12.08M 2026-09
Eisai JPY 16.7B 8.03B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Exelixis USD 268.42M 20.01M 2026-09
Geron USD 5.73M 15.26M 2026-09
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09